TenSixteen Bio

0 followers


TenSixteen Bio is the first company to leverage somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics to treat age-related diseases.

Industries

Headquarters

Employees

Links

Org chart

Eric Rose
Head of Clinical Informatics
Alex Bick
Scientific Co-founder
Andi Dhroso
Senior Bioinformatics Data Scientist